|
|
Volumn 61, Issue 7, 2018, Pages 1522-1527
|
|
Empagliflozin in women with type 2 diabetes and cardiovascular disease – an analysis of EMPA-REG OUTCOME®
a
b
c
d
d
e
|
|
Author keywords
Cardiovascular disease; Heart failure; Mortality; SGLT2 inhibition; Type 2 diabetes; Women
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANGIOTENSIN RECEPTOR ANTAGONIST;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
EMPAGLIFLOZIN;
HEMOGLOBIN A1C;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
INSULIN;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
METFORMIN;
PLACEBO;
SULFONYLUREA;
ANTIDIABETIC AGENT;
BENZHYDRYL DERIVATIVE;
BIOLOGICAL MARKER;
GLUCOSIDE;
GLYCOSYLATED HEMOGLOBIN;
HEMOGLOBIN A1C PROTEIN, HUMAN;
ADULT;
ANTIHYPERTENSIVE THERAPY;
ARTICLE;
CARDIOVASCULAR DISEASE;
CONTROLLED STUDY;
CORONARY ARTERY DISEASE;
DEATH;
DRUG WITHDRAWAL;
FEMALE;
GENITAL TRACT INFECTION;
HOSPITALIZATION;
HUMAN;
INCIDENCE;
KIDNEY DISEASE;
MAJOR CLINICAL STUDY;
MALE;
MIDDLE AGED;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
URINARY TRACT INFECTION;
AGED;
BLOOD;
COMORBIDITY;
COMPARATIVE STUDY;
DRUG EFFECT;
GLUCOSE BLOOD LEVEL;
METABOLISM;
MORTALITY;
RISK FACTOR;
SEX FACTOR;
TREATMENT OUTCOME;
AGED;
BENZHYDRYL COMPOUNDS;
BIOMARKERS;
BLOOD GLUCOSE;
CARDIOVASCULAR DISEASES;
COMORBIDITY;
DIABETES MELLITUS, TYPE 2;
FEMALE;
GLUCOSIDES;
GLYCATED HEMOGLOBIN A;
HUMANS;
HYPOGLYCEMIC AGENTS;
INCIDENCE;
MALE;
MIDDLE AGED;
RISK FACTORS;
SEX FACTORS;
TREATMENT OUTCOME;
|
|
EID: 85048033200
PISSN: 0012186X
EISSN: 14320428
Source Type: Journal
DOI: 10.1007/s00125-018-4630-2 Document Type: Article |
|
Times cited : (55)
|
|
References (11)
|
